Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...
Delhi Lieutenant Governor Taranjit Singh Sandhu on Monday said the younger generation has the potential to determine the course of India's progress in fields such as artificial intelligence, ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Highlighting how the delay in the National Eligibility-Entrance Test Superspeciality (NEET SS) 2025 counselling process is ...
Vivek Ramaswamy has clinched the Republican nomination for Ohio governor, setting up a high-stakes contest against Amy Acton.
Billionaires in both parties loom large over the political landscape, and more are jumping into the ring with high-profile ...
3don MSN
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
The competition is far behind.
Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including ...
The identity of a Massachusetts State Police trooper killed by a wrong-way driver in Lynnfield on Wednesday morning has been ...
UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...
(ARGX) stock is in focus as the FDA expands the label of its blockbuster therapy Vyvgart for a broader group of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results